Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ADITYA RALI

Allopathic & Osteopathic Physicians Ophthalmology Retina Specialist

NPI
1972009827
CMS profile
11318454
Location
WASHINGTON, DC

General Payments · PY2022–2024

$3,018.06

  • Reported across 41 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$955.70

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $955.70 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alcon Laboratories Inc $504.77 5
Apellis Pharmaceuticals, Inc. $145.79 2
Genentech, Inc. $131.00 1
Alimera Sciences, Inc. $51.09 2
Astellas Pharma US Inc $45.94 2
Sandoz Inc. $39.01 2
ABBVIE INC. $21.55 1
Genentech USA, Inc. $16.55 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $598.16 7
PY2023 $1,464.20 18
PY2024 $955.70 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.55 10/14/2024 Food and Beverage Undisputed 01/23/2026 1105360282 CMS
Alcon Vision LLC $122.06 01/17/2024 Food and Beverage Undisputed 01/23/2026 1110705144 CMS
Alcon Vision LLC $106.17 02/06/2024 Food and Beverage Undisputed 01/23/2026 1110705142 CMS
Alcon Vision LLC $143.88 03/13/2024 Food and Beverage Undisputed 01/23/2026 1110705148 CMS
Alcon Vision LLC $8.36 04/30/2024 Food and Beverage Undisputed 01/23/2026 1110705140 CMS
Alcon Vision LLC $124.30 04/30/2024 Food and Beverage Undisputed 01/23/2026 1110705146 CMS
Alimera Sciences, Inc. $26.62 10/28/2024 Food and Beverage Undisputed 01/23/2026 1092838578 CMS
Alimera Sciences, Inc. $24.47 12/05/2024 Food and Beverage Undisputed 01/23/2026 1092836817 CMS
Apellis Pharmaceuticals, Inc. $14.69 10/03/2024 Food and Beverage Undisputed 01/23/2026 1154016082 CMS
Apellis Pharmaceuticals, Inc. $131.10 11/22/2024 Food and Beverage Undisputed 01/23/2026 1154016084 CMS
Astellas Pharma US Inc $24.43 09/30/2024 Food and Beverage Undisputed 01/23/2026 1139404915 CMS
Astellas Pharma US Inc $21.51 12/02/2024 Food and Beverage Undisputed 01/23/2026 1139439218 CMS
Genentech USA, Inc. $16.55 11/07/2024 Food and Beverage Undisputed 01/23/2026 1132972503 CMS
Genentech, Inc. $131.00 07/23/2024 Food and Beverage Undisputed 01/23/2026 1132972505 CMS
Sandoz Inc. $25.88 06/20/2024 Food and Beverage Undisputed 01/23/2026 1089370298 CMS
Sandoz Inc. $13.13 11/21/2024 Food and Beverage Undisputed 01/23/2026 1089370402 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.